[{"authors":["admin"],"categories":null,"content":"I am a physician scientist working in the Tavazoie lab at The Rockefeller University. In my research, I focus on how the immune system interacts with cancer cells, and I apply wet-lab and computational methods to study these interactions.\nI obtained an M.D. from the University of Freiburg in Germany, where I also completed my experimental doctoral thesis in Molecular Nephrology in the laboratory of Tobias Huber. I subsequently worked as a resident physician and research fellow in Internal Medicine at Charité in Berlin.\nMy main research interest lies in determining the factors that shape the interplay between immune and cancer cells. In particular, I study the impact of germline variation on individual patients\u0026rsquo; anti-tumor immune responses. Additionally, I am invested in characterizing the mechanisms that enable cancer cells to evade immune responses and understanding the requirements of effective anti-tumor immunity.\nI am currently looking for a position to establish a research group addressing these topics using experimental tumor immunology and computations systems biology approaches. Please contact me if my profile is of interest.\n","date":-62135596800,"expirydate":-62135596800,"kind":"taxonomy","lang":"en","lastmod":-62135596800,"objectID":"2525497d367e79493fd32b198b28f040","permalink":"/authors/admin/","publishdate":"0001-01-01T00:00:00Z","relpermalink":"/authors/admin/","section":"authors","summary":"I am a physician scientist working in the Tavazoie lab at The Rockefeller University. In my research, I focus on how the immune system interacts with cancer cells, and I apply wet-lab and computational methods to study these interactions.","tags":null,"title":"Benjamin Ostendorf","type":"authors"},{"authors":null,"categories":null,"content":"Flexibility This feature can be used for publishing content such as:\n Online courses Project or software documentation Tutorials  The courses folder may be renamed. For example, we can rename it to docs for software/project documentation or tutorials for creating an online course.\nDelete tutorials To remove these pages, delete the courses folder and see below to delete the associated menu link.\nUpdate site menu After renaming or deleting the courses folder, you may wish to update any [[main]] menu links to it by editing your menu configuration at config/_default/menus.toml.\nFor example, if you delete this folder, you can remove the following from your menu configuration:\n[[main]] name = \u0026quot;Courses\u0026quot; url = \u0026quot;courses/\u0026quot; weight = 50  Or, if you are creating a software documentation site, you can rename the courses folder to docs and update the associated Courses menu configuration to:\n[[main]] name = \u0026quot;Docs\u0026quot; url = \u0026quot;docs/\u0026quot; weight = 50  Update the docs menu If you use the docs layout, note that the name of the menu in the front matter should be in the form [menu.X] where X is the folder name. Hence, if you rename the courses/example/ folder, you should also rename the menu definitions in the front matter of files within courses/example/ from [menu.example] to [menu.\u0026lt;NewFolderName\u0026gt;].\n","date":1536451200,"expirydate":-62135596800,"kind":"section","lang":"en","lastmod":1536451200,"objectID":"59c3ce8e202293146a8a934d37a4070b","permalink":"/courses/example/","publishdate":"2018-09-09T00:00:00Z","relpermalink":"/courses/example/","section":"courses","summary":"Learn how to use Academic's docs layout for publishing online courses, software documentation, and tutorials.","tags":null,"title":"Overview","type":"docs"},{"authors":null,"categories":null,"content":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academic:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 2 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"74533bae41439377bd30f645c4677a27","permalink":"/courses/example/example1/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example1/","section":"courses","summary":"In this tutorial, I\u0026rsquo;ll share my top 10 tips for getting started with Academic:\nTip 1 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":null,"title":"Example Page 1","type":"docs"},{"authors":null,"categories":null,"content":"Here are some more tips for getting started with Academic:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\nTip 4 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum. Sed ac faucibus dolor, scelerisque sollicitudin nisi. Cras purus urna, suscipit quis sapien eu, pulvinar tempor diam. Quisque risus orci, mollis id ante sit amet, gravida egestas nisl. Sed ac tempus magna. Proin in dui enim. Donec condimentum, sem id dapibus fringilla, tellus enim condimentum arcu, nec volutpat est felis vel metus. Vestibulum sit amet erat at nulla eleifend gravida.\nNullam vel molestie justo. Curabitur vitae efficitur leo. In hac habitasse platea dictumst. Sed pulvinar mauris dui, eget varius purus congue ac. Nulla euismod, lorem vel elementum dapibus, nunc justo porta mi, sed tempus est est vel tellus. Nam et enim eleifend, laoreet sem sit amet, elementum sem. Morbi ut leo congue, maximus velit ut, finibus arcu. In et libero cursus, rutrum risus non, molestie leo. Nullam congue quam et volutpat malesuada. Sed risus tortor, pulvinar et dictum nec, sodales non mi. Phasellus lacinia commodo laoreet. Nam mollis, erat in feugiat consectetur, purus eros egestas tellus, in auctor urna odio at nibh. Mauris imperdiet nisi ac magna convallis, at rhoncus ligula cursus.\nCras aliquam rhoncus ipsum, in hendrerit nunc mattis vitae. Duis vitae efficitur metus, ac tempus leo. Cras nec fringilla lacus. Quisque sit amet risus at ipsum pharetra commodo. Sed aliquam mauris at consequat eleifend. Praesent porta, augue sed viverra bibendum, neque ante euismod ante, in vehicula justo lorem ac eros. Suspendisse augue libero, venenatis eget tincidunt ut, malesuada at lorem. Donec vitae bibendum arcu. Aenean maximus nulla non pretium iaculis. Quisque imperdiet, nulla in pulvinar aliquet, velit quam ultrices quam, sit amet fringilla leo sem vel nunc. Mauris in lacinia lacus.\nSuspendisse a tincidunt lacus. Curabitur at urna sagittis, dictum ante sit amet, euismod magna. Sed rutrum massa id tortor commodo, vitae elementum turpis tempus. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aenean purus turpis, venenatis a ullamcorper nec, tincidunt et massa. Integer posuere quam rutrum arcu vehicula imperdiet. Mauris ullamcorper quam vitae purus congue, quis euismod magna eleifend. Vestibulum semper vel augue eget tincidunt. Fusce eget justo sodales, dapibus odio eu, ultrices lorem. Duis condimentum lorem id eros commodo, in facilisis mauris scelerisque. Morbi sed auctor leo. Nullam volutpat a lacus quis pharetra. Nulla congue rutrum magna a ornare.\nAliquam in turpis accumsan, malesuada nibh ut, hendrerit justo. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque sed erat nec justo posuere suscipit. Donec ut efficitur arcu, in malesuada neque. Nunc dignissim nisl massa, id vulputate nunc pretium nec. Quisque eget urna in risus suscipit ultricies. Pellentesque odio odio, tincidunt in eleifend sed, posuere a diam. Nam gravida nisl convallis semper elementum. Morbi vitae felis faucibus, vulputate orci placerat, aliquet nisi. Aliquam erat volutpat. Maecenas sagittis pulvinar purus, sed porta quam laoreet at.\n","date":1557010800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1557010800,"objectID":"1c2b5a11257c768c90d5050637d77d6a","permalink":"/courses/example/example2/","publishdate":"2019-05-05T00:00:00+01:00","relpermalink":"/courses/example/example2/","section":"courses","summary":"Here are some more tips for getting started with Academic:\nTip 3 Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis posuere tellus ac convallis placerat. Proin tincidunt magna sed ex sollicitudin condimentum.","tags":null,"title":"Example Page 2","type":"docs"},{"authors":["Bernardo Tavora","Tobias Mederer","Kai Wessel","Simon Ruffing","Mahan Sadjadi","Marc Missmahl","**Benjamin N. Ostendorf**","Xuhang Liu","Ji-Young Kim","Olaf Olsen","Alana L. Welm","Hani Goodarzi","Sohail F. Tavazoie"],"categories":null,"content":"","date":1590969600,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1590969600,"objectID":"173392d9f1117a1f0fa490b730d41a6e","permalink":"/publication/tavora-2020/","publishdate":"2020-06-04T22:33:48.041627Z","relpermalink":"/publication/tavora-2020/","section":"publication","summary":"","tags":null,"title":"Tumoural induction of a Slit2 axon-guidance signal in the endothelium drives metastasis","type":"publication"},{"authors":["**Benjamin N. Ostendorf**","Jana Bilanovic","Nneoma Adaku","Kimia N. Tafreshian","Bernardo Tavora","Roger D. Vaughan","Sohail F. Tavazoie"],"categories":null,"content":"","date":1588291200,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1588291200,"objectID":"5dcdabe3cb9be37736eece15da0d5d45","permalink":"/publication/ostendorf-2020-a/","publishdate":"2020-06-05T21:14:33.982782Z","relpermalink":"/publication/ostendorf-2020-a/","section":"publication","summary":"Heritable APOE variants in patients with melanoma influence anti-tumor immunity and modulate metastatic progression and response to immunotherapy.","tags":null,"title":"Common Germline Variants of the Human APOE Gene Modulate Melanoma Progression and Survival","type":"publication"},{"authors":["**Benjamin N. Ostendorf**†","Sohail F. Tavazoie† (†corresponding authors)"],"categories":null,"content":"","date":1583020800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1583020800,"objectID":"177942e42129c83357315ea21a9c750a","permalink":"/publication/ostendorf-2020/","publishdate":"2020-04-04T22:33:48.041627Z","relpermalink":"/publication/ostendorf-2020/","section":"publication","summary":"Cancer cells need to acquire specific molecular traits in order to spread to distant organs. In this issue of *Developmental Cell*, Marsh et al. show that autophagy restricts the outgrowth of breast cancer metastases in contrast to its impact on primary tumor progression.","tags":null,"title":"Autophagy Suppresses Breast Cancer Metastasis","type":"publication"},{"authors":["Masoud F. Tavazoie","Ilana Pollack","Raissa Tanqueco","**Benjamin N. Ostendorf**","Bernardo S. Reis","Foster C. Gonsalves","Isabel Kurth","Celia Andreu-Agullo","Mark L. Derbyshire","Jessica Posada","Shugaku Takeda","Kimia N. Tafreshian","Eric Rowinsky","Michael Szarek","Roger J. Waltzman","Elizabeth A. Mcmillan","Connie Zhao","Monica Mita","Alain Mita","Bartosz Chmielowski","Michael A. Postow","Antoni Ribas","Daniel Mucida","Sohail F. Tavazoie"],"categories":null,"content":"","date":1514764800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1514764800,"objectID":"81faa7267ff4b6231e909ecdbe0894ce","permalink":"/publication/tavazoie-2018/","publishdate":"2020-04-04T22:33:48.040807Z","relpermalink":"/publication/tavazoie-2018/","section":"publication","summary":"Therapeutic harnessing of adaptive immunity via checkpoint inhibition has transformed the treatment of many cancers. Despite unprecedented long-term responses, most patients do not respond to these therapies. Immunotherapy non-responders often harbor high levels of circulating myeloid-derived suppressor cells (MDSCs)-an immunosuppressive innate cell population. Through genetic and pharmacological approaches, we uncovered a pathway governing MDSC abundance in multiple cancer types. Therapeutic liver-X nuclear receptor (LXR) agonism reduced MDSC abundance in murine models and in patients treated in a first-in-human dose escalation phase 1 trial. MDSC depletion was associated with activation of cytotoxic T lymphocyte (CTL) responses in mice and patients. The LXR transcriptional target ApoE mediated these effects in mice, where LXR/ApoE activation therapy elicited robust anti-tumor responses and also enhanced T cell activation during various immune-based therapies. We implicate the LXR/ApoE axis in the regulation of innate immune suppression and as a target for enhancing the efficacy of cancer immunotherapy in patients.","tags":null,"title":"LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer","type":"publication"},{"authors":["**Benjamin N. Ostendorf**†","Eva Flenner","Anne Flörcken","Jörg Westermann† (†corresponding authors)"],"categories":null,"content":"","date":1514764800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1514764800,"objectID":"3b80369e7fbc4a1f5b97160dd0c3e6b3","permalink":"/publication/ostendorf-2018/","publishdate":"2020-04-04T22:33:48.04016Z","relpermalink":"/publication/ostendorf-2018/","section":"publication","summary":"Recent reports have revealed myelodysplastic syndromes (MDS) to arise from cancer stem cells phenotypically similar to physiological hematopoietic stem cells. Myelodysplastic hematopoiesis maintains a hierarchical organization, but the proportion of several hematopoietic compartments is skewed and multiple surface markers are aberrantly expressed. These aberrant antigen expression patterns hold diagnostic and therapeutic promise. However, eradication of MDS requires targeting of early myelodysplasia propagating stem cells. This warrants an exact assessment of the differentiation stage at which aberrant expression occurs in transformed hematopoiesis. Here, we report results on the prospective and extensive dissection of the hematopoietic hierarchy in 20 patients with either low-risk MDS or MDS with excess blasts and compare it to hematopoiesis in patients with non-malignancy-associated cytopenia or B cell lymphoma without bone marrow infiltration. We found patients with MDS with excess blasts to exhibit characteristic expansions of specific immature progenitor compartments. We also identified the aberrant expression of several markers including ALDH, CLL-1, CD44, and CD47 to be specific features of hematopoiesis in MDS with excess blasts. We show that amongst these, aberrant CLL-1 expression manifested at the early uncommitted hematopoietic stem cell level, suggesting a potential role as a therapeutic target.","tags":null,"title":"Phenotypic characterization of aberrant stem and progenitor cell populations in myelodysplastic syndromes","type":"publication"},{"authors":["**Benjamin N. Ostendorf**","Leo Hansmann","Wolf-Dieter Ludwig","Bernd Dörken","Richard Ratei","Jörg Westermann"],"categories":null,"content":"","date":1475280000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1475280000,"objectID":"d979309f93bd2131b2d2cbc4d6e8bb5c","permalink":"/publication/ostendorf-2016/","publishdate":"2020-04-04T22:33:48.045333Z","relpermalink":"/publication/ostendorf-2016/","section":"publication","summary":"","tags":null,"title":"[Flow-cytometric immunophenotyping in clinical diagnostics]","type":"publication"},{"authors":["**Benjamin N. Ostendorf**†","Theis H. Terwey","Philipp G. Hemmati","Dirk Böhmer","Uwe Pleyer","Renate Arnold (†corresponding author)"],"categories":null,"content":"","date":1435708800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1435708800,"objectID":"a384c530e90a0624225dc682f5fddaad","permalink":"/publication/ostendorf-2015-c/","publishdate":"2020-04-04T22:33:48.042553Z","relpermalink":"/publication/ostendorf-2015-c/","section":"publication","summary":"Abstract Patients receiving radiotherapy often experience toxicity of the skin and mucous membranes. While radiotherapy is a mainstay of myeloablative conditioning for allogeneic hematopoietic stem cell transplantation (ASCT), no risk factors for radiotoxicity have been identified in this setting. Here, we report on a patient with excessive radiation-induced toxicity after ASCT who carried a heterozygous mutation in the Ataxia telangiectasia mutated (ATM) gene. This is the first case to suggest a genetic basis for increased radiotoxicity after myeloablative ASCT.","tags":["ataxia telangiectasia mutated","hematopoietic stem cell transplantation","radiosensitivity","radiotoxicity","risk factor"],"title":"Severe radiotoxicity in an allogeneic transplant recipient with a heterozygous ATM mutation","type":"publication"},{"authors":["**Benjamin N. Ostendorf**","Olga Blau","Lutz Uharek","Igor W. Blau","Olaf Penack"],"categories":null,"content":"","date":1420070400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1420070400,"objectID":"b50678085d00996f2240dc556d93696b","permalink":"/publication/ostendorf-2015/","publishdate":"2020-04-04T22:33:48.039685Z","relpermalink":"/publication/ostendorf-2015/","section":"publication","summary":"Endogenous danger signals are increasingly recognized in the pathogenesis of graft-versus-host disease (GVHD). Uric acid (UA) is a known danger signal and is released from injured cells during conditioning for allogeneic hematopoietic stem cell transplantation (HSCT), but its role in GVHD is unclear. Here, we retrospectively analyze 228 consecutive patients with malignant diseases undergoing HSCT from 10/10-HLA-matched donors. Low UA levels at the time of HSCT (day 0) were significantly associated with acute GVHD grades II-IV in univariate (HR 0.836, p = 0.0072) and multivariate analyses (HR 0.815, p = 0.0047). There was no significant association between UA levels and overall survival, non-relapse mortality, and relapse. This is the first report demonstrating a negative association between UA levels and acute GVHD. Due to the easy assessment and established pharmaceutical modification of UA, our findings are potentially clinically relevant. Confirmation in independent cohorts and further investigations into underlying mechanisms, such as reduced antioxidative capacity in hypouricemia, are warranted.","tags":null,"title":"Association between low uric acid levels and acute graft-versus-host disease","type":"publication"},{"authors":["**Benjamin N. Ostendorf**†","Hendrik Nogai","Claudia D. Baldus","Thomas Burmeister","Renate Arnold (†corresponding author)"],"categories":null,"content":"","date":1420070400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1420070400,"objectID":"53d64a44b4b78c3b8fdd7e093840bdfe","permalink":"/publication/ostendorf-2015-a/","publishdate":"2020-04-04T22:33:48.044595Z","relpermalink":"/publication/ostendorf-2015-a/","section":"publication","summary":"The management of patients with chronic myeloid leukemia (CML) in advanced phases is challenging and requires the consideration of different treatment approaches, including targeted therapy with tyrosine kinase inhibitors, cytotoxic chemotherapy, and allogeneic stem cell transplantation. Here, we present the case of a patient with CML in mixed phenotype blast phase illustrating the integration of these strategies and demonstrating the need for close monitoring of treatment response in order to individually adjust treatment regimens.","tags":null,"title":"BCR-ABL Mutation-Guided Therapy for CML Blast Crisis: A Case Report","type":"publication"},{"authors":["Anne Flörcken","Anna Takvorian","Anju Singh","Anne Gerhardt","**Benjamin N. Ostendorf**","Bernd Dörken","Antonio Pezzutto","Jörg Westermann"],"categories":null,"content":"","date":1420070400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1420070400,"objectID":"e33e6fcbb5f2a7d54ac005150de0c0a7","permalink":"/publication/florcken-2015/","publishdate":"2020-04-04T22:33:48.038338Z","relpermalink":"/publication/florcken-2015/","section":"publication","summary":"Induction of myeloid-derived suppressor cells is an important mechanism leading to tolerance against tumors. Phenotypic characterization of MDSC has been established and heterogeneous populations with monocytic or granulocytic features have been characterized. Increased levels of MDSC have been described in metastatic renal cell carcinoma and seem to correlate with an adverse outcome. As MDSC constitute only small populations in peripheral blood of cancer patients, it is highly important to achieve technically optimized conditions for quantification. Different cell preparation techniques - besides freezing and thawing - are potential sources of substantial variation. Our study was focused on an optimized quantification of MDSC in pB of healthy donors and patients with mRCC, in whom major technical sources of variation were analyzed. Whole blood and peripheral blood mononuclear cells were used for the flow cytometric quantification of MDSC in the pB of mRCC patients and healthy donors. We compared (1) analysis in whole blood vs. PBMC after Ficoll gradient centrifugation and (2) immediate analysis after blood drawing vs. analysis one day later. Finally, in order to evaluate our optimized technical approach, pB of 15 patients with histologically confirmed mRCC under treatment with either sunitinib or sorafenib was analyzed. No difference in the number of MDSC was observed after analysis in whole blood vs. PBMC. In contrast, the time point of analysis was a source of substantial variation (one day later vs. immediate analysis after blood drawing). In conclusion, for optimal analysis of MDSC, immediate analysis of whole blood after blood drawing rather than one day later seems to be most appropriate under the aspect of practical feasibility and reliability. Using this method, we were able to confirm both (a) increased numbers of MDSC in patients with mRCC and (b) a decrease of MDSC under sunitinib therapy.","tags":null,"title":"Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinoma","type":"publication"},{"authors":["**Benjamin N. Ostendorf**†","Christian F. Jehn","Lam G. Vuong","Hendrik Nogai","Philipp G. Hemmati","Bernhard Gebauer","Olaf Penack","Igor W. Blau","Ioannis Anagnostopoulos","Renate Arnold (†corresponding author)"],"categories":null,"content":"","date":1401580800,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1401580800,"objectID":"e0f2a651794724512a449ae744d4ee40","permalink":"/publication/ostendorf-2014-b/","publishdate":"2020-04-04T22:33:48.043302Z","relpermalink":"/publication/ostendorf-2014-b/","section":"publication","summary":"Allogeneic stem cell transplant recipients are prone to infections by various organisms. Tuberculosis (TB) represents a rare infectious complication, especially in countries non-endemic for TB.","tags":null,"title":"Synchronous tuberculosis, Epstein-Barr virus-associated lymphoproliferative disorder and cytomegalovirus infection in an allogeneic transplant recipient: a case report","type":"publication"},{"authors":["**Benjamin N. Ostendorf**†","Philipp le Coutre","Theo D. Kim","Alfonso Quintás-Cardama (†corresponding author)"],"categories":null,"content":"","date":1388534400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1388534400,"objectID":"2002246cc4f158d01f89b4558baa44e4","permalink":"/publication/ostendorf-2014-d/","publishdate":"2020-04-04T22:33:48.044043Z","relpermalink":"/publication/ostendorf-2014-d/","section":"publication","summary":"Targeted therapy of Philadelphia chromosome-positive chronic myeloid leukemia (CML) using the tyrosine kinase inhibitor imatinib mesylate has been one of the most striking achievements in modern cancer medicine. However, while imatinib can establish long-term remission in many cases, resistance to or intolerance of imatinib is eventually experienced by a substantial number of patients. Subsequent advances have led to the development of novel tyrosine kinase inhibitors (TKIs). One such inhibitor, nilotinib, was rationally designed to increase its affinity and specificity for the oncogenic tyrosine kinase Bcr-Abl compared with imatinib and has been shown to be effective after imatinib failure. Recently, nilotinib has been shown to be more effective when used as first-line therapy of chronic phase CML.","tags":null,"title":"Nilotinib","type":"publication"},{"authors":["**Benjamin N. Ostendorf**"],"categories":null,"content":"","date":1362096000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1362096000,"objectID":"7544b9299cd9f370c5b99de32cc22130","permalink":"/publication/ostendorf-2013-a/","publishdate":"2020-04-07T18:55:57.712656Z","relpermalink":"/publication/ostendorf-2013-a/","section":"publication","summary":"","tags":null,"title":"[A novel motif regulating internalization and degradation of the glomular slit diaphgram protein podocin]","type":"publication"},{"authors":["**Benjamin N. Ostendorf**"],"categories":null,"content":"","date":1356998400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1356998400,"objectID":"72a0f99ba8e7dc593bb5b79976a70524","permalink":"/publication/ostendorf-2013/","publishdate":"2020-04-07T18:55:57.711791Z","relpermalink":"/publication/ostendorf-2013/","section":"publication","summary":"","tags":null,"title":"[Hematological Neoplasias]","type":"publication"},{"authors":["Markus Gödel*","**Benjamin N. Ostendorf***","Jessica Baumer","Katrin Weber","Tobias B. Huber (*equal contribution)"],"categories":null,"content":"","date":1356998400,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1356998400,"objectID":"730287ea4cb947440b73e5b658a58924","permalink":"/publication/godel-2013/","publishdate":"2020-04-04T22:33:48.039282Z","relpermalink":"/publication/godel-2013/","section":"publication","summary":"Mutations in the gene NPHS2 are the most common cause of hereditary steroid-resistant nephrotic syndrome. Its gene product, the stomatin family member protein podocin represents a core component of the slit diaphragm, a unique structure that bridges the space between adjacent podocyte foot processes in the kidney glomerulus. Dislocation and misexpression of slit diaphragm components have been described in the pathogenesis of acquired and hereditary nephrotic syndrome. However, little is known about mechanisms regulating cellular trafficking and turnover of podocin. Here, we discover a three amino acids-comprising motif regulating intracellular localization of podocin in cell culture systems. Mutations of this motif led to markedly reduced degradation of podocin. These findings give novel insight into the molecular biology of the slit diaphragm protein podocin, enabling future research to establish the biological relevance of podocin turnover and localization.","tags":null,"title":"A novel domain regulating degradation of the glomerular slit diaphragm protein podocin in cell culture systems","type":"publication"},{"authors":["**Benjamin N. Ostendorf**","Richard L. Oehler","John N. Greene"],"categories":null,"content":"","date":1293840000,"expirydate":-62135596800,"kind":"page","lang":"en","lastmod":1293840000,"objectID":"3b4366b1c97381ec846f2b4ec6df782f","permalink":"/publication/ostendorf-2011/","publishdate":"2020-04-04T22:33:48.042068Z","relpermalink":"/publication/ostendorf-2011/","section":"publication","summary":"Staphylococcus intermedius is known primarily for its role as a commensal and pathogen in dogs and a variety of other animals. It has also been reported as a cause of human infection in a limited number of cases. Here, we report a case of S. intermedius wound infection in a 47-year-old woman with postradiation skin changes. Transmission occurred most likely through direct skin contact with her pet dog. This case highlights the possibility of pet-transmitted infections in predisposed patients and should raise awareness of possibly drug-resistant pathogens in animal reservoirs.","tags":["coagulase-positive staphylococcus","pet infection"],"title":"Human Staphylococcus intermedius Infection in a Patient With Postradiation Changes","type":"publication"}]